Nav1.8作为外周神经系统疼痛信号传导的重要钠通道，具有机制选择性高、不影响中枢、依赖风险低等特征，被视为镇痛治疗的新一代靶点。2025年 ...

Network pharmacology results suggest that voltage-gated sodium channel subtypes (Nav1.1, Nav1.2, and Nav1.6) may be the targets for RC prevention of DE. Furthermore, the Western blot analysis revealed ...

KHN702片是公司自主研发的高选择性NaV1.8抑制剂，是一种新型的非阿片类镇痛药物，无成瘾性，属于化药1类创新药。前期已完成的研究结果显示KHN702片安全性较好，且在多种疼痛模型中具有良好的治疗作用，预期临床应用前景较好。

March 28, 2025: We checked for the latest GTA 6 news, including renewed speculation around the trailer 2 release date. When is GTA 6 coming out? Given how many years it takes to create open worlds ...

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid pain management drugs. | Latigo Biotherapeutics has whipped together a $150 ...

Todd Howard introduced The Elder Scrolls 6 teaser trailer at E3 in 2018. Study it as closely as you dare. Really drink it in. Because this first glimpse is going to be the last official look at ...

FDA finds benzene contamination, Tronox to close a pigment plant, Sofinnova launches a European biotech fund, and more ...

Here’s how it works. The last we heard on GTA 6 came in the form of the game's first proper trailer, at the end of 2023. This was followed by the news that the game is targeting Fall 2025.

CHATHAM, NJ / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house ...

【康弘药业：KHN702片获得药物临床试验批准通知书】财联社3月24日电，康弘药业(002773.SZ)公告称，公司近日收到国家药品监督管理局签发的《药物临床试验批准通知书》，同意KHN702片开展临床试验。该药品为自主研发的高选择性NaV1.8抑制剂，属于化药1类创新药，预期临床应用前景较好。但药品研发具有不确定性，投资者需谨慎决策。 “特别声明：以上作品内容(包括在内的视频、图片或音频)为凤凰 ...

Central Laboratory, Department of Neurology and Neurosurgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 20062, China School of Medicine and Life Sciences, Chengdu ...